Tianjin Medical University Second Hospital
2 clinical trials · 2 recruiting · OTHER
Trials by Tianjin Medical University Second Hospital
RECRUITINGPhase 2NCT07475403
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
This study aims to evaluate whether urinary tumor DNA (utDNA) can guide treatment duration in patients with unresectable very-high-risk non-muscle-invasive bladder cancer (VHR...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 531 location
Bladder CancerLiquid BiopsyImmunotherapy
RECRUITINGNCT06031636
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
The purpose of this study is to evaluate the efficacy and safety of Oncolytic Adenovirus(H101) combined with PD-1 inhibitor in patients with advanced malignant pleural...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 151 location
Malignant Pleural Mesothelioma, Advanced